EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Geographical distribution, disease association and diversity of Klebsiella pneumoniae K/L and O antigens in India: roadmap for vaccine development

Varun Shamanna, Srikanth Srinivas, Natacha Couto, Geetha Nagaraj, Shyama Prasad Sajankila, Harshitha Gangaiah Krishnappa, Kavitha Arakalgud Kumar, David M Aanensen, Ravikumar Kadahalli Lingegowda, Nihr Global Health Research Unit On Genomic Surveillance-India Consortium

Microbial Genomics · 2024

DOI: 10.1099/mgen.0.001271 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Genomics, 2024. Verfasst von Varun Shamanna und 9 weiteren Autor:innen. Beteiligte Einrichtung: Central Research Laboratory, KIMS, Bengaluru, India. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Klebsiella Infections, Serogroup, O Antigens. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, National Institute for Health and Care Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Klebsiella pneumoniae poses a significant healthcare challenge due to its multidrug resistance and diverse serotype landscape. This study aimed to explore the serotype diversity of 1072 K . pneumoniae and its association with geographical distribution, disease severity and antimicrobial/virulence patterns in India. Whole-genome sequencing was performed on the Illumina platform, and genomic analysis was carried out using the Kleborate tool. The analysis revealed a total of 78 different KL types, among which KL64 ( n =274/1072, 26 %), KL51 ( n =249/1072, 24 %), and KL2 ( n =88/1072, 8 %) were the most prevalent. In contrast, only 13 distinct O types were identified, with O1/O2v1 ( n =471/1072, 44 %), O1/O2v2 ( n =353/1072, 33 %), and OL101 ( n =66/1072, 6 %) being the predominant serotypes. The study identified 114 different sequence types (STs) with varying serotypes, with ST231 being the most predominant. O serotypes were strongly linked with STs, with O1/O2v1 predominantly associated with ST231. Simpson’s diversity index and Fisher’s exact test revealed higher serotype diversity in the north and east regions, along with intriguing associations between specific serotypes and resistance profiles. No significant association between KL or O types and disease severity was observed. Furthermore, we found the specific association of virulence factors yersiniabactin and aerobactin ( P 0.05). Conventionally described hypervirulent clones (i.e. KL1 and KL2) in India lacked typical virulent markers (i.e. aerobactin), contrasting with other regional serotypes (KL51). The cumulative distribution of KL and O serotypes suggests that future vaccines may have to include either ~20 KL or four O types to cover >85 % of the carbapenemase-producing Indian K. pneumoniae population. The results highlight the necessity for comprehensive strategies to manage the diverse landscape of K. pneumoniae strains across different regions in India. Understanding regional serotype dynamics is pivotal for targeted surveillance, interventions, and tailored vaccine strategies to tackle the diverse landscape of K. pneumoniae infections across India. This article contains data hosted by Microreact.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Klebsiella pneumoniaeKlebsiella InfectionsSerogroupO AntigensIndiaHumansWhole Genome SequencingVaccine DevelopmentVirulence FactorsVirulenceGenome, BacterialBacterial VaccinesDrug Resistance, Multiple, BacterialAntigens, BacterialPhylogenyAntigens, Surface

Stichwörter der Autor:innen

IndiaK-Locus typesK. pneumoniaeO antigenSerotypesWGSvaccine

Substanzen

O AntigensVirulence FactorsBacterial VaccinesK antigensAntigens, BacterialAntigens, Surface

Autor:innen und Institutionen

  • Central Research Laboratory, KIMS, Bengaluru, India.
  • Department of Biotechnology, NMAM Institute of Technology, Nitte, Udupi, India.
  • Centre for Genomic Pathogen Surveillance, Pandemic Sciences Institute, University of Oxford, Oxford, UK.

Förderung

  • Wellcome Trust
  • National Institute for Health and Care Research

Zitieren

APA

Shamanna, V., Srinivas, S., Couto, N., Nagaraj, G., Sajankila, S. P., Krishnappa, H. G., Kumar, K. A., Aanensen, D. M., Lingegowda, R. K., & Nihr Global Health Research Unit On Genomic Surveillance-India Consortium (2024). Geographical distribution, disease association and diversity of Klebsiella pneumoniae K/L and O antigens in India: roadmap for vaccine development. Microbial Genomics. https://doi.org/10.1099/mgen.0.001271

Vancouver

Shamanna V, Srinivas S, Couto N, Nagaraj G, Sajankila SP, Krishnappa HG, et al. Geographical distribution, disease association and diversity of Klebsiella pneumoniae K/L and O antigens in India: roadmap for vaccine development. Microbial Genomics. 2024. doi:10.1099/mgen.0.001271

BibTeX
@article{Shamanna2024,
  author = {Shamanna, Varun and Srinivas, Srikanth and Couto, Natacha and Nagaraj, Geetha and Sajankila, Shyama Prasad and Krishnappa, Harshitha Gangaiah and Kumar, Kavitha Arakalgud and Aanensen, David M and Lingegowda, Ravikumar Kadahalli and Nihr Global Health Research Unit On Genomic Surveillance-India Consortium},
  title = {Geographical distribution, disease association and diversity of Klebsiella pneumoniae K/L and O antigens in India: roadmap for vaccine development},
  journal = {Microbial Genomics},
  year = {2024},
  doi = {10.1099/mgen.0.001271}
}
Kostenlos starten →